In the current study, to avoid the possibility of inherent differences between two tumour biopsies (as observed in earlier studies, Egyházi et al, 1997) we measured total (active and inactive) MGMT using an ELISA assay and active MGMT using our functional activity assay. This evidence concerns the gene MGMT and neoplasm.